Enhanced patient support services improve patient persistence with multiple sclerosis treatment
Jane Roche,1 Yvonne McCarry,2 Karen Mellors31Beaumont Hospital, Dublin, 2Quintiles Ireland Ltd, Fairview, Dublin, Ireland; 3Merck Serono Ltd, Feltham, UKBackground: Subcutaneous interferon beta-1a (sc IFN β-1a) therapy (44 µg or 22 µg, three times weekly) improves relap...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-06-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/enhanced-patient-support-services-improve-patient-persistence-with-mul-a17162 |